Your browser doesn't support javascript.
loading
Recurrent Loss-of-Function Mutations Reveal Costs to OAS1 Antiviral Activity in Primates.
Carey, Clayton M; Govande, Apurva A; Cooper, Juliane M; Hartley, Melissa K; Kranzusch, Philip J; Elde, Nels C.
Afiliação
  • Carey CM; Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
  • Govande AA; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Cooper JM; Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
  • Hartley MK; Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
  • Kranzusch PJ; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Elde NC; Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, UT 84112, USA. Electronic address: nelde@genetics.utah.edu.
Cell Host Microbe ; 25(2): 336-343.e4, 2019 02 13.
Article em En | MEDLINE | ID: mdl-30713099

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Primatas / 2',5'-Oligoadenilato Sintetase / Mutação Tipo de estudo: Health_economic_evaluation Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Primatas / 2',5'-Oligoadenilato Sintetase / Mutação Tipo de estudo: Health_economic_evaluation Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article